LILAK
Liberty Latin America Ltd.
LILAK lost money over the past year, so it has no meaningful PE right now.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
LILAK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
LILAK's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
LILAK PE Valuation
LILAK has no meaningful PE right now: it lost money over the past year.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
LILAK Forward outlook
There aren't enough analyst estimates for LILAK to show an outlook.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
LILAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.90 | +$2.43 |
| Q2 2026 | -$0.46 | +$4.90 |
| Q1 2026 | -$2.25 | +$1.39 |
| Q4 2025 | -$2.78 | +$0.23 |
| Q3 2025 | -$3.33 | -$0.58 |
| Q2 2025 | -$5.36 | -$4.90 |
| Q1 2025 | -$3.64 | -$3.53 |
| Q4 2024 | -$3.01 | -$2.69 |
LILAK is still losing money, but far less than before: $0.90 per share over the past year, against $5.36 at its worst in mid-2025.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over LILAK in the latest year-over-year earnings comparison.
LILAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +0.4% |
| Q2 2026 | $1.1B | +1.5% |
| Q1 2026 | $1.1B | -0.1% |
| Q4 2025 | $1.2B | +0.8% |
| Q3 2025 | $1.1B | +2.1% |
| Q2 2025 | $1.1B | -2.8% |
| Q1 2025 | $1.1B | -1.4% |
| Q4 2024 | $1.2B | -1.1% |
LILAK has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -0.6 points |
| Q2 2026 | 16% | +47 points |
| Q1 2026 | 13% | +1.6 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 17% | +52 points |
| Q2 2025 | -31% | -41 points |
| Q1 2025 | 12% | +3.4 points |
| Q4 2024 | 11% | +1.4 points |
LILAK's operating margin was 16% last quarter, down 0.6 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
LILAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.2M | -21% |
| Q2 2026 | $96M | +4953% |
| Q1 2026 | -$57.1M | +$15M |
| Q4 2025 | $320.1M | +36% |
| Q3 2025 | $56M | +9.8% |
| Q2 2025 | $1.9M | -88% |
| Q1 2025 | -$72.1M | +$14.3M |
| Q4 2024 | $234.9M | +2.8% |
LILAK generated $403M in free cash flow over the past year, up 83% from the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
LILAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.2% | -6.4M shares |
| 1 year | -15% | -33.8M shares |
| 3 years | -15% | -34.8M shares |
| 5 years | -30% | -84.1M shares |
| Available history | -8.4% | -17.9M shares |
LILAK has 195M diluted shares, down 15% from a year ago, with $117M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $90.9M |
| Q2 2026 | $12.1M |
| Q1 2026 | $14.3M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
LILAK spent $117M buying back its own shares over the past year, after none the year before.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over LILAK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
LILAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.1x | High |
| Q2 2026 | 5.0x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 7.4x | High |
| Q3 2025 | 7.6x | High |
| Q2 2025 | 16.2x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 8.1x | High |
LILAK's net debt is about 5.0 years of its operating earnings (EBITDA), down from 7.6 years a year ago.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
LILAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.0 | Neutral |
| Stochastic | 72.3 | Neutral |
LILAK's weekly RSI is 65 (neutral) and its Stochastic is 72 (neutral).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
LILAK PE vs Communication Services Sector
| Metric | LILAK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
LILAK has no meaningful PE right now: it lost money over the past year.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
LILAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.53 | 15% above |
| 20 week MA | $8.26 | 18% above |
| 50 week MA | $8.03 | 22% above |
| 100 week MA | $7.43 | 31% above |
| 200 week MA | $7.80 | 25% above |
LILAK has stronger trend alignment. LILAK is above 5 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
LILAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $11.2 | -43% |
| 2021 | $11.2 | $11.5 | +2.1% |
| 2022 | $11.5 | $7.74 | -33% |
| 2023 | $7.74 | $7.34 | -5.2% |
| 2024 | $7.34 | $6.38 | -13% |
| 2025 | $6.38 | $7.59 | +19% |
| 2026 YTD | $7.59 | $9.77 | +29% |
LILAK has finished lower in four of the last six years. It's up 29% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over LILAK on returns for 2026, with the stronger performance.